Companies: 10,795·Total market cap: $144.5T
Sagimet Biosciences Inc.

Sagimet Biosciences Inc.

SGMTNASDAQHealthcare● Active
$6.53
$-0.23(-3.40%)
Market Cap$212759134
P/E Ratio—
52W High$11.41
52W Low$4.5
Overview
Stock ranking:Biotechnology·Healthcare·View All Market Cap Rankings →

Sagimet Biosciences Inc. (SGMT) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · SGMT · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-1.35sgmt eps ttm · sgmt earnings per shareEarnings history
PE Ratio (TTM)—sgmt pe ratio ttm · sgmt price to earningsPE Ratio deep dive
Revenue (TTM)0.00sgmt revenue ttm · sgmt annual revenueFull revenue history
Dividend YieldNo Dividenddoes sgmt pay dividends · sgmt dividend yieldDividend history
Shares Outstanding32.3Msgmt shares outstanding · sgmt floatShares outstanding history
Next EarningsAug 12, 2026Est.sgmt earnings date · sgmt next earningsEarnings history

Explore Sagimet Biosciences Inc. Data

sgmt stock data · financials
Market Cap$212.8Msgmt market cap · sgmt valuation
Analyst Forecast$8 · Buy
DividendsNo Dividenddoes sagimet biosciences inc. pay dividends · sgmt dividend yield
Revenue—sagimet biosciences inc. annual revenue · sgmt revenue
EarningsEPS $-1.58-8.97%sgmt earnings · sgmt eps
PE Ratio—sgmt pe ratio · sgmt price to earnings

Financial Snapshot

Full Financials
FY 2025Revenue$0.00
202320242025
sagimet biosciences inc. revenue · sgmt revenue 2025
FY 2025Net Income-$51.0M▼ 12.01% YoY
202320242025
sagimet biosciences inc. net income · sgmt profit 2025
FY 2025EPS$-1.58▼ 8.97% YoY
202320242025
sgmt eps · sagimet biosciences inc. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$43.5MEPS: $-1.35View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy7 analystsis sgmt a buy · sgmt analyst rating
Strong Buy
0
Buy
6
Hold
1
Sell
0
Strong Sell
0
12-Month Price Target
$8.00Low
$6.53Current
$8.00Avg Target22.51% upside
$8.00High
sgmt price target · sgmt 12 month forecast

Total: 7 · Buy rate: 85.7%

The SGMT analyst consensus is Buy, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month price target is $8.00, representing +22.51% upside from the current price of $6.53.

Stock Performance

Full History
1D-3.40%
1W-4.81%
1M-15.30%
3M+21.38%
YTD+10.30%
1Y+22.51%
5Y-59.06%

About Sagimet Biosciences Inc.

CEODavid A. Happel
IPO DateJul 17, 2023
Employees14
CountryUS
Websitesagimet.com

Sagimet Biosciences Inc. is a biopharmaceutical company with drug candidates in clinical trials, specializing in developing therapies that target fatty acid synthase (FASN) inhibition. These treatment…

BiotechnologyHealthcareNASDAQUS

what is sagimet biosciences inc. · sgmt stock overview · sagimet biosciences inc. company profile · who is sagimet biosciences inc. ceo · sgmt NASDAQ · sagimet biosciences inc. headquarters · sagimet biosciences inc. business segments

About Stock Overview & Key Data

Sagimet Biosciences Inc. (SGMT) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jul 17, 2023. As of the latest trading session, SGMT stock price is $6.53, with a market capitalization of $212.8M. The stock has returned +22.51% over the past 12 months and +10.30% year-to-date.

According to 7 Wall Street analysts, the consensus rating for Sagimet Biosciences Inc. stock is Buy, with an average 12-month price target of $8.00. In fiscal year 2025, Sagimet Biosciences Inc. reported revenue of — and net income of -$51.0M. For detailed data — including Sagimet Biosciences Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Sagimet Biosciences Inc. (SGMT) stock price is $6.53. The stock is traded on NASDAQ under the ticker symbol SGMT. The 52-week range is $4.50 – $11.41.

SGMT stock priceSGMT quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice